$90.74 (0.699%)

Volume: 771.823k

Closed: Mar 24, 2023

Hollow Logo Score: -2.540
BioMarin Pharmaceutical Inc. Stock
$90.74 (0.699%)

Volume: 771.823k

Closed: Mar 24, 2023

Score Hollow Logo -2.540
NASDAQ:BMRN

BioMarin Pharmaceutical Inc. Stock Signals

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -2.540 17 days ( 9.37 % )
Last Price $90.74 0.699 %
High/ Low $89.34 - $91.16 0.750%
Chg 7 Days -1.01 % $91.67 $90.74
Chg 30 Days -12.01 % $103.12 $90.74
Chg 12 mos 12.19 % $80.88 $90.74
Trend - 3 mos -16.63 % Width: 21.67 %
Trend - 12 mos 31.97 % Width: 37.61 %
Pred. range - 3 mos $71.14 - $86.55 -21.61 % - -4.62 %
Pred. range - 12 mos $116.88 - $160.84 28.81 % - 77.25 %
Short mv avg 3 mos Sell 2023-03-21 - 4 days
Long mv avg 3 mos Sell 2023-02-09 - 31 days
Short/Long mv avg 3 mos Sell 2023-02-14 - 28 days
Short mv avg 12 mos Buy 2023-03-20 - 5 days
Long mv avg 12 mos Sell 2023-02-27 - 20 days
Short/Long mv avg 12 mos Sell 2023-03-07 - 14 days
Pivot Short Sell 2023-03-15 - 8 days
Bollinger Buy 2023-03-07 - 14 days
MACD Buy No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT